Center for Substance Abuse Research | CESAR l Center for Substance Abuse Research l University of Maryland

Table 2: Common Drugs Detected in 8 Xylazine Positive Specimens, Feb-May 2023

MD-EDDS: Xylazine Detected in 8% of Positive Specimens from Meritus Medical Center; All Contained Fentanyl

CESAR Director Jessica Magidson Named an MPower Professor

Countryside road with Mobile Treatment Unit

Roads to Recovery: Mobile Treatment Units Bring Help and Hope To Rural Maryland

Baltimore, Md. + Cape Town, S.A.

Applying a mutual capacity building model to inform peer provider programs in South Africa and the United States

Urine collection vial and printout of test results

UMD-led System Shows Success in Helping Hospitals Understand Fentanyl Use in their Communities

Text: Xylazine | New EDDS Findings | Study finds 78% of urines positive for xylazine also contained fentanyl

Xylazine Now Included in CESAR EDDS Urine Drug Test Panels

Jessica Magidson

Jessica Magidson Named New Director of CESAR, Now the ‘Center for Substance Use, Addiction & Health Research’

Four dashboard thumbnails

New EDDS Dashboards Launched: 17 HCA Healthcare and 4 Scripps EDs

Figure 1 graphic showing 5% fentanyl testing rate

Only 5% of Overdose Patients Tested for Fentanyl

Publications

Items of Interest